(Q33857605)

29 July 2017

1 reference

title

TGF-betas and TGF-beta receptors in atherosclerosis (English)

1 reference

29 July 2017

1 reference

McCaffrey TA

1

1 reference

29 July 2017

1 March 2000

1 reference

Cytokine and Growth Factor Reviews

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

1-2

1 reference

29 July 2017

103-114

1 reference

Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I).

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Restenosis after successful coronary angioplasty in patients with single-vessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Vascular smooth muscle cell growth kinetics in vivo in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Spontaneous regression of restenosis: an angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Could atherosclerosis originate from defective smooth muscle cell death (apoptosis)?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Normal embryo fibroblasts release transforming growth factors in a latent form

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Transforming growth factor-beta 1 binds to immobilized fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Transforming growth factor-beta complexes with thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Production of transforming growth factor beta 1 during repair of arterial injury

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Deactivation of macrophages by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Localization of PDGF-B protein in macrophages in all phases of atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

In vivo effect of TGF- beta 1. Enhanced intimal thickening by administration of TGF- beta 1 in rabbit arteries injured with a balloon catheter

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Growth factor expression in aorta of normotensive and hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Developmentally regulated transforming growth factor-beta 1 action on vascular smooth muscle growth in the SHR

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Conformation of glutathione adduct and oxidized forms of platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Structure and expression of the promoter for the human type II transforming growth factor-beta receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Characterization of the promoter region of the human transforming growth factor-beta type II receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

Glucocorticoid resistance caused by reduced expression of the glucocorticoid receptor in cells from human vascular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900034-9

7 January 2021

10.1016/S1359-6101(99)00034-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10708958